Vext Science, Inc.
VEXTF
$0.1096
$0.00383.59%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.04% | -2.40% | 1.07% | -1.69% | -5.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.04% | -2.40% | 1.07% | -1.69% | -5.36% |
| Cost of Revenue | 27.10% | 46.75% | 85.75% | 90.20% | 48.75% |
| Gross Profit | -39.92% | -54.44% | -56.73% | -48.63% | -37.03% |
| SG&A Expenses | 89.87% | 86.31% | 38.62% | 41.18% | -2.72% |
| Depreciation & Amortization | 60.79% | 85.45% | 59.68% | 39.91% | 73.02% |
| Other Operating Expenses | 94.44% | 41.67% | -116.67% | -253.23% | -109.84% |
| Total Operating Expenses | 48.19% | 63.39% | 65.01% | 63.28% | 32.94% |
| Operating Income | -2,294.33% | -538.45% | -304.12% | -184.88% | -93.44% |
| Income Before Tax | -33.20% | -528.82% | -217.96% | -49.79% | -155.06% |
| Income Tax Expenses | 116.79% | 109.38% | 96.56% | 75.46% | -489.94% |
| Earnings from Continuing Operations | -250.02% | -194.69% | -122.98% | -59.72% | -11.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -250.02% | -194.69% | -122.98% | -59.72% | -11.43% |
| EBIT | -2,294.33% | -538.45% | -304.12% | -184.88% | -93.44% |
| EBITDA | -120.34% | -132.24% | -106.43% | -89.43% | -49.68% |
| EPS Basic | -180.49% | -160.62% | -115.89% | -76.06% | -5.70% |
| Normalized Basic EPS | -217.02% | -50,800.00% | -425.78% | -197.11% | -139.94% |
| EPS Diluted | -185.71% | -164.41% | -120.31% | -74.70% | 12.00% |
| Normalized Diluted EPS | -216.31% | -50,800.00% | -425.78% | -197.11% | -139.94% |
| Average Basic Shares Outstanding | 56.84% | 43.40% | 29.44% | 18.48% | -5.95% |
| Average Diluted Shares Outstanding | 57.30% | 42.91% | 28.92% | 18.06% | -6.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
